Glossary of terms related to intellectual property and access to medical tools

MSF and co-authors argue in The Lancet HIV that the production of new COVID-19 drugs should not come at the expense of HIV drug supply.

Thousands of deaths from a fungal infection of the brain called cryptococcal meningitis (CM) could potentially be averted every year in South Africa if an antifungal medicine called flucytosine is widely available.

It is unacceptable that people living with HIV are still dying because the tests, treatment and care for life-threatening infections are not available.

Shortages of first-line antibiotics, which are essential to treat a wide range of common infections, are a major public health threat

This week in Korea, the 16 countries of the Regional Comprehensive Economic Partnership (RCEP) agreement are meeting in Incheon for the 20th round of negotiations on this multilateral trade deal.

Manila is set to host the 18th round of the multilateral trade deal — the Regional Comprehensive Economic Partnership (RCEP) that encompasses 50% of the global population.

Today millions of people living with HIV in South-East Asia are receiving treatment and leading healthy lives thanks to affordable generic antiretroviral (ARVs) medicines.

Dr Maria Guevara says affordable generics have transformed medical treatment, yet intellectual property provisions in a China-led regional trade deal could block access to life-saving drugs for millions in Africa and Asia